n-methylaspartate has been researched along with Behavior Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Canzar, S; Christian, KM; Dawson, TM; Dawson, VL; Eacker, S; Hsu, KS; Kim, NS; Li, W; Lin, YT; Ming, GL; Nguyen, HN; Ringeling, FR; Song, H; Temme, SJ; Worley, P; Xiao, B; Yoon, KJ; Zhou, Y | 1 |
| Chen, Z; Li, Z; Zhang, H; Zhong, Z; Zhou, Z | 1 |
| Gupta, N; Kouser, M; Liu, S; Ochoa, CF; Powell, CM; Reimers, JM; Speed, HE; Xuan, Z | 1 |
| Eby, GA; Eby, KL | 1 |
| Cepeda, C; Levine, MS | 1 |
| de Montigny, C; Debonnel, G | 1 |
| Meador, KJ | 1 |
4 review(s) available for n-methylaspartate and Behavior Disorders
| Article | Year |
|---|---|
Magnesium for treatment-resistant depression: a review and hypothesis.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; D-Aspartic Acid; Depression; Depressive Disorder; Depressive Disorder, Major; Fast Foods; Humans; Imipramine; Magnesium; Magnesium Deficiency; Mental Disorders; Models, Neurological; N-Methylaspartate; Randomized Controlled Trials as Topic; Suicide, Attempted | 2010 |
Where do you think you are going? The NMDA-D1 receptor trap.
Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Calcium; Corpus Striatum; Diffusion; Dopamine; Drug Design; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Models, Neurological; N-Methylaspartate; Nervous System Diseases; Neurons; Organ Culture Techniques; Protein Interaction Mapping; Protein Subunits; Protein Transport; Rats; Receptors, Dopamine D1; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synaptic Membranes | 2006 |
Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders.
Topics: Animals; Central Nervous System; Dopamine; Humans; Mental Disorders; N-Methylaspartate; Neuropeptides; Phencyclidine; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Steroids; Synaptic Transmission | 1996 |
Neurodevelopmental effects of antiepileptic drugs.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Brain; Epilepsy; Epoxy Compounds; Female; Folic Acid; Free Radicals; Humans; Ischemia; Mental Disorders; N-Methylaspartate; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Factors; Teratogens | 2002 |
3 other study(ies) available for n-methylaspartate and Behavior Disorders
| Article | Year |
|---|---|
CYFIP1 Dosages Exhibit Divergent Behavioral Impact via Diametric Regulation of NMDA Receptor Complex Translation in Mouse Models of Psychiatric Disorders.
Topics: Adaptor Proteins, Signal Transducing; Animals; Autism Spectrum Disorder; Disease Models, Animal; DNA Copy Number Variations; Mental Disorders; Mice; Mice, Inbred C57BL; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; RNA; RNA, Messenger | 2022 |
Ginsenoside Rg3 exerts anti-depressive effect on an NMDA-treated cell model and a chronic mild stress animal model.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Depression; Disease Models, Animal; Female; Ginsenosides; Hippocampus; Humans; Mental Disorders; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neurons; Phosphorylation; Signal Transduction; Stress, Psychological | 2017 |
Autism-Associated Insertion Mutation (InsG) of Shank3 Exon 21 Causes Impaired Synaptic Transmission and Behavioral Deficits.
Topics: Animals; Disease Models, Animal; Excitatory Postsynaptic Potentials; Exons; Exploratory Behavior; Female; Grooming; Hippocampus; Locomotion; Male; Maze Learning; Mental Disorders; Mice; Mice, Transgenic; Microfilament Proteins; Mutagenesis, Insertional; Mutation; N-Methylaspartate; Nerve Tissue Proteins; Nesting Behavior; Sodium Channel Blockers; Synaptic Transmission; Tetrodotoxin | 2015 |